Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1178)
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
133,618
Price
$40.24
Total Value
$5.38M
Shares Held After
6,299,097
% of Holdings
2.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
6,700
Price
$66.33
Total Value
$444.39K
Shares Held After
767,780
% of Holdings
0.9%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,575
Price
$65.46
Total Value
$234.01K
Shares Held After
774,480
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,725
Price
$64.63
Total Value
$628.54K
Shares Held After
778,055
% of Holdings
1.2%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
22,177
Price
$6.75
Total Value
$149.69K
Shares Held After
176,713
% of Holdings
11.2%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
7,500
Price
$32.64
Total Value
$244.80K
Shares Held After
18,802
% of Holdings
28.5%
Vericel Corp (VCEL)
Wotton Paul K — Director
Shares
2,500
Price
$33.05
Total Value
$82.62K
Shares Held After
26,302
% of Holdings
8.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
6,510,416
Price
$11.52
Total Value
$75.00M
Shares Held After
15,203,995
% of Holdings
42.8%
ARVINAS, INC. (ARVN)
Teel Randy — Director
Shares
9,657
Price
$9.94
Total Value
$95.97K
Shares Held After
287,218
% of Holdings
3.3%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
830
Price
$101.18
Total Value
$83.98K
Shares Held After
83,243
% of Holdings
1.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
12,119
Price
$100.35
Total Value
$1.22M
Shares Held After
84,073
% of Holdings
12.6%
ARVINAS, INC. (ARVN)
Berkowitz Noah — Chief Medical Officer
Shares
11,108
Price
$9.94
Total Value
$110.38K
Shares Held After
191,395
% of Holdings
5.5%
REGENXBIO Inc. (RGNX)
PAKOLA STEVE — Chief Medical Officer
Shares
15,309
Price
$11.02
Total Value
$168.71K
Shares Held After
232,617
% of Holdings
6.2%
ARVINAS, INC. (ARVN)
Cacace Angela M — Chief Scientific Officer
Shares
9,657
Price
$9.94
Total Value
$95.97K
Shares Held After
182,966
% of Holdings
5.0%
Viridian Therapeutics, Inc.\DE (VRDN)
Fairmount Funds Management LLC — Director
Shares
1,176,470
Price
$17.00
Total Value
$20.00M
Shares Held After
5,090,928
% of Holdings
23.1%
ARVINAS, INC. (ARVN)
Loomis David K — VP, Chief Accounting Officer
Shares
1,919
Price
$9.94
Total Value
$19.07K
Shares Held After
40,193
% of Holdings
4.6%
ARVINAS, INC. (ARVN)
Saik Andrew — Chief Financial Officer
Shares
11,139
Price
$9.94
Total Value
$110.69K
Shares Held After
193,128
% of Holdings
5.5%
Annexon, Inc. (ANNX)
Carson William H. — Director
Shares
8,000
Price
$5.78
Total Value
$46.24K
Shares Held After
78,405
% of Holdings
10.2%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Thompson Rahsaan — Chief Legal & Compliance
Shares
1,794
Price
$11.30
Total Value
$20.27K
Shares Held After
48,125
% of Holdings
3.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
14,207
Price
$53.25
Total Value
$756.57K
Shares Held After
1,870,042
% of Holdings
0.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
75,293
Price
$52.38
Total Value
$3.94M
Shares Held After
1,884,249
% of Holdings
3.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
10,500
Price
$51.31
Total Value
$538.76K
Shares Held After
1,959,542
% of Holdings
0.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
27,613
Price
$50.10
Total Value
$1.38M
Shares Held After
1,970,042
% of Holdings
1.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
115,479
Price
$49.45
Total Value
$5.71M
Shares Held After
1,997,655
% of Holdings
5.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
75,801
Price
$48.61
Total Value
$3.68M
Shares Held After
2,113,134
% of Holdings
3.5%
GENELUX Corp (GNLX)
Smalling Ralph — Head of Regulatory
Shares
270
Price
$2.98
Total Value
$804.49
Shares Held After
67,803
% of Holdings
0.4%
GENELUX Corp (GNLX)
Cappello Joseph — Chief Technical Officer
Shares
605
Price
$2.97
Total Value
$1.80K
Shares Held After
154,549
% of Holdings
0.4%
GENELUX Corp (GNLX)
Zindrick Thomas — President and CEO
Shares
2,798
Price
$2.94
Total Value
$8.23K
Shares Held After
532,051
% of Holdings
0.5%
GENELUX Corp (GNLX)
Yu Yong — Chief Scientific Officer
Shares
605
Price
$2.97
Total Value
$1.80K
Shares Held After
149,706
% of Holdings
0.4%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
33,948
Price
$0.67
Total Value
$22.75K
Shares Held After
1,239,060
% of Holdings
2.7%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$41.50
Total Value
$1.04M
Shares Held After
1,298,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
5,812
Price
$0.67
Total Value
$3.89K
Shares Held After
413,001
% of Holdings
1.4%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
81,678
Price
$0.67
Total Value
$54.72K
Shares Held After
5,804,290
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$580.44
Total Value
$69.65K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
514
Price
$579.85
Total Value
$298.04K
Shares Held After
40,633
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
227
Price
$578.73
Total Value
$131.37K
Shares Held After
41,147
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
964
Price
$577.80
Total Value
$557.00K
Shares Held After
41,374
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$576.93
Total Value
$121.15K
Shares Held After
42,338
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
658
Price
$575.33
Total Value
$378.56K
Shares Held After
42,548
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$574.38
Total Value
$331.99K
Shares Held After
43,206
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$573.18
Total Value
$227.55K
Shares Held After
43,784
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,292
Price
$572.39
Total Value
$739.52K
Shares Held After
44,181
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,356
Price
$571.43
Total Value
$774.85K
Shares Held After
45,473
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,019
Price
$570.21
Total Value
$1.15M
Shares Held After
46,829
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,165
Price
$569.50
Total Value
$663.47K
Shares Held After
48,848
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$580.45
Total Value
$46.44K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
591
Price
$579.80
Total Value
$342.66K
Shares Held After
18,956
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
476
Price
$578.42
Total Value
$275.33K
Shares Held After
19,547
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
893
Price
$577.59
Total Value
$515.79K
Shares Held After
20,023
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
89
Price
$576.68
Total Value
$51.32K
Shares Held After
20,916
% of Holdings
0.4%
Showing 751–800 of 1178 transactions (page 16 of 24)